Sex matters–insights from testing drug efficacy in an animal model of pancreatic cancer

HIGHLIGHTS

• What: This study reported a markedly enhanced overall survival among females compared to males despite a more rapid dose reduction during each treatment cycle.
• Who: Benjamin Schulz and collaborators from the Rudolf-Zenker-Institute of Experimental Surgery, Rostock University Medical Center, Institute of Pharmacology and Toxicology, Rostock University Medical Center, Rostock, Germany have published the paper: Sex Matters-Insights from Testing Drug Efficacy in an Animal Model of Pancreatic Cancer, in the Journal: Cancers 2024, 16, 1901. of /2024/
• How: To evaluate the inhibitors of KRASSOS1 MEK1/2 and PI3K in 6606PDA cells . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.